CC[C@@]12CCCN3CC[C@@]4(c5ccc(OC)c(O)c5N(C(C)=O)[C@H]4CC1)[C@H]32
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?